This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.C Johannessen Landmark , PG Larsson , E Rytter , SI Johannessen . Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions. Epilepsy Res. 2009; 87(1): 31–39.
2.J Hayes , P Prah , I Nazareth , etal. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS One. 2011; 6(12): e28725.
4.DA Adedinsewo , DJ Thurman , YH Luo , etal. Valproate prescriptions for nonepilepsy disorders in reproductive-age women. Birth Defects Res A Clin Mol Teratol. 2013; 97(6): 403–408.
5.S Gentile . Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 2006; 8(3): 207–220.
6.S Gentile . Bipolar disorder and pregnancy: to treat or not to treat? BMJ. 2012; 345: e7367.
7.FJ Vajda , TJ O'Brien , JE Graham , CM Lander , MJ Eadie . Dose dependence of fetal malformations associated with valproate. Neurology. 2013; 81(11): 999–1003.
8.KJ Meador . Comment: valproate dose effects differ across congenital malformations. Neurology. 2013; 81(11): 1002.
9.PB Pennell , AM Klein , N Browning , etal. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav. 2012; 24(4): 449–456.
11.S Koch , K Titze , RB Zimmermann , etal. Long-term epilepsy and neuropsychological consequences of maternal anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia. 1999; 40(9): 1237–1243.
13.HC Steinhausen , G Losche , S Koch , H Helge . The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr. 1994; 83(9): 955–960.
14.G Losche , HC Steinhausen , S Koch , H Helge . The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr. 1994; 83(9): 961–966.
16.N Adab , D Jacoby , D Smith , D Chadwick . Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2001; 70(1): 15–21.
17.CS Dean , H Hailey , SJ Moore , etal. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002; 39(4): 251–259.
19.K Eriksson , K Viinikainen , A Monkkonen , etal. Children exposed to valproate in utero—population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res. 2005; 65(3): 189–200.
20.K Viinikainen , K Eriksson , A Monkkonen , etal. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy Behav. 2006; 9(4): 636–640.
21.SV Thomas , B Ajaykumar , K Sindhu , etal. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav. 2008; 13(1): 229–236.
22.KJ Meador , GA Baker , N Browning , etal. for the NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009; 360(16): 1597–1605.
23.KM McVearry , WD Gaillard , J VanMeter , KJ Meador . A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav. 2009; 16(4): 609–616.
24.MJ Cohen , KJ Meador , N Browning , etal. Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral/functioning at age 3 years. Epilepsy Behav. 2011; 22(2): 240–246.
25.KJ Meador , GA Baker , N Browning , etal. for the NEAD Study Group. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012; 78(16): 1207–1214.
26.KJ Meador , GA Baker , N Browning , etal. for the NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013; 12(3): 244–252.
27.MJ Cohen , KJ Meador , N Browning , etal, for the NEAD study group. Fetal antiepileptic drug exposure: adaptive and emotional/behavioral functioning at age 6 years. Epilepsy Behav. 2013; 29(2): 308–315.
28.KJ Meador , GA Baker , N Browning , etal, for the NEAD Study Group. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011; 134(Pt 2): 396–404.
29.N Adab , U Kini , J Vinten , etal. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004; 75(11): 1575–1583.
30.J Vinten , N Adab , U Kini , etal, for the Liverpool and Manchester Neurodevelopment Study Group. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology. 2005; 64(6): 949–954.
31.J Vinten , RL Bromley , J Taylor , etal, on behalf of the Liverpool and Manchester Neurodevelopment Group. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav. 2009; 14(1): 197–201.
32.RL Bromley , G Mawer , J Love , etal, on behalf of the Liverpool and Manchester Neurodevelopment Group. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia. 2010; 51(10): 2058–2065.
33.R Shallcross , RL Bromley , B Irwin , etal, on behalf of the Liverpool/Manchester Neurodevelopment Group and the UK Epilepsy and Pregnancy Register. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology. 2011; 76(4): 383–389.
34.RL Bromley , G Mawer , J Clayton-Smith , GA Baker , on behalf of the Liverpool and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology. 2008; 71(28): 1923–1924.
35.RL Bromley , GE Mawer , M Briggs , etal, on Behalf of the Liverpool and Manchester Neurodevelopment Group.. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013; 84(6): 637–643.
36.CP Johnson , SM Myers . American Academy of Pediatrics Council on Children with Disabilities. Identification and evaluation of children with autistic spectrum disorders. Pediatrics. 2007; 120(5): 1183–1215.
38.C Nadebaum , V Anderson , F Vajda , etal. Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology. 2011; 76(8): 719–726.
39.C Cummings , M Stewart , M Stevenson , J Morrow , J Nelson . Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child. 2011; 96(7): 643–647.
40.E Kantola-Sorsa , E Gaily , M Isoaho , M Korkman . Neuropsychological outcomes in children of mothers with epilepsy. J Int Neuropsychol Soc. 2007; 13(4): 642–652.
41.J Christensen , TK Grønborg , MJ Sørensen , etal. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013; 309(16): 1696–1703.
42.G Veiby , AK Daltvei , S Schjølberg , etal. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia. 2013; 54(8): 1462–1472.
44.G Veiby , BA Engelsen , NE Gilhus . Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol. 2013; 70(11): 1367–1374.
45.JM Thomas , AL Benham , M Gean , etal. Practice parameters for the psychiatric assessment of infant and toddlers (0-36 months). American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997; 36(10 Suppl): S21–S36.
47.S Gentile . SSRIs in pregnancy and lactation with emphasis on neurodevelopmental outcome. CNS Drugs. 2005; 19(7): 623–633.
48.A Thapar , T Fowler , F Rice , etal. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry. 2003; 160(11): 1985–1989.
49.HJ Larsson , WW Eaton , KK Madsen . Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol. 2005; 161(10): 916–925.
50.CM Hultman , P Sparén , S Cnattingius . Perinatal risk factors for infantile autism. Epidemiology. 2002; 13(4): 417–423.
51.PJ Easterbrook , JA Berlin , R Gopalan , DR Matthews . Publication bias in clinical research. Lancet. 1991; 337(8746): 867–872.
54.AW Fox , ML Diamond , EL Spiering . Migraine during pregnancy: options for therapy. CNS Drugs. 2005; 19(6): 465–481.
56.LB Holmes , S Hernandez-Diaz . Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol. 2012; 94(8): 599–606.
58.E Campbell , F Kennedy , B Irwin , etal. Malformation risks of antiepileptic drug monotherapies in pregnancy. J Neurol Neurosurg Psychiatry. 2013; Nov; 84(11): e2.
59.S Gentile . Lithium in pregnancy: the need to treat, the duty to ensure safety. Exp Opin Drug Saf. 2012; 11(3): 425–437.
60.FJ Vajda , J Graham , A Roten , etal. Teratogenicity of the newer antiepileptic drugs—the Australian experience. J Clin Neurosci. 2012; 19(1): 57–59.
61.S Gentile . Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull. 2010; 36(3): 518–544.
62.D Kjaer , J Christensen , BH Becha , etal. Preschool behavioral problems in children prenatally exposed to antiepileptic drugs—a follow-up study. Epilepsy Behav. 2013; 29(2): 407–411.
63.R Boden , M Lundgren , L Brandt , etal. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ. 2012; 345: e7085.
66.G Wright , M Patel . Focal migraine and pregnancy. BMJ. 1986; 293(6561): 1557–1558.
67.EA MacGregor . Headache in pregnancy. Neurol Clin. 2012; 30(3): 835–866.